Short answer
LIFECORE BIOMEDICAL, INC. DE (LFCR) filed an 8-K current report with the SEC on October 20, 2026 reporting Item 8.01 (Other Events). Special meeting set for November 4, 2026, to vote on adoption of the merger agreement and proposed merger.
LIFECORE BIOMEDICAL, INC. DE 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Special meeting set for November 4, 2026, to vote on adoption of the merger agreement and proposed merger
- November 4, 2026 record date determines stockholder voting eligibility
- Merger process advances toward shareholder approval following the September 27, 2026 agreement
- Preliminary and definitive proxy statements will provide merger terms and management-interest disclosures for investor review
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LIFECORE BIOMEDICAL, INC. DE 8-K filings
Get the next LFCR 8-K as it lands
Follow LFCR for push alerts, or ask the research agent what this filing means.